Access to Medicines and Health Products programme. annual report 2021

Abstract

Equitable access to health products is a global priority – all citizens should have affordable access to the essential medicines, vaccines and health products that they need. The COVID-19 pandemic has focused attention on weaknesses and vulnerabilities in health-care systems including interruptions to supply chains and higher prices for essential health-care products. The Access to Medicines and Health Products (‎AMP)‎ programme in the WHO Regional Office for Europe focuses on health system strengthening, and supports Member States in the development, revision and implementation of comprehensive pharmaceutical sector policies that underpin sustainable access to essential and affordable high-quality medicines and medical products. In addition to the technical work covering regulation of medicines and medical devices, pharmacovigilance, selection and responsible use of medicines, and developing medicine pricing and reimbursement policies, the AMP programme has a convening role, bringing together international experts to promote cross-country dialogue and share country experiences. The 2021 annual report of the AMP programme highlights some of the work done by the Regional Office in collaboration with agencies and partners to improve access to safe, effective, quality and affordable essential medicines and vaccines.